Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Biocryst Pharmaceuticals Inc (BCRX)  
$7.92 0.34 (4.49%) as of 4:30 Wed 1/7


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 209,920,000
Market Cap: 1.66(B)
Last Volume: 3,901,941 Avg Vol: 4,148,128
52 Week Range: $6.41 - $11.19
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  1115
Guru Rank Value     : 0
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioCryst Pharmaceuticals is a commercial-stage biotechnology company that discovers oral, small-molecule medicines. Co. focuses on oral treatments for rare diseases. Co.'s drug/drug candidates include: ORLADEYO™ (berotralstat), an oral serine protease inhibitor targeting kallikrein that is being developed for the prevention of Hereditary Angioedema attacks; BCX9930, an oral factor D inhibitor for the treatment of complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors for the treatment of fibrodysplasia ossificans progressive; and RAPIVAB® (peramivir injection), an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 183,601
Total Buy Value $0 $0 $0 $1,048,338
Total People Bought 0 0 0 10
Total Buy Transactions 0 0 0 10
Total Shares Sold 214,263 284,263 284,263 295,650
Total Sell Value $1,562,332 $2,158,200 $2,158,200 $2,227,259
Total People Sold 2 3 3 3
Total Sell Transactions 6 7 7 9
End Date 2025-10-09 2025-07-08 2025-01-07 2024-01-08

   
Records found: 476
  Page 1 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Barnes Alane P Chief Legal Officer   •       •      –    2025-12-22 4 AS $7.65 $166,563 D/D (21,773) 398,751 -1%     
   Gayer Charles K President and CCO   •       •      –    2025-12-22 4 OE $3.22 $371,896 D/D 74,233 952,583     -
   Barnes Alane P Chief Legal Officer   •       •      –    2025-12-19 4 D $7.41 $125,244 D/D (16,902) 420,524     -
   Stonehouse Jon P Chief Executive Officer   •       •      –    2025-12-19 4 D $7.41 $457,886 D/D (61,793) 1,323,429     -
   Gayer Charles K President and CCO   •       •      –    2025-12-19 4 D $7.41 $85,045 D/D (11,477) 878,350     -
   Stonehouse Jon P Chief Executive Officer   •       •      –    2025-12-18 4 GA $0.00 $0 I/I 20,000 40,000     -
   Stonehouse Jon P Chief Executive Officer   •       •      –    2025-12-18 4 GD $0.00 $0 D/D 20,000 1,385,222     -
   Barnes Alane P Chief Legal Officer   •       –      –    2025-12-17 4 A $0.00 $0 D/D 121,700 437,426     -
   Ghias Babar Chief Financial Officer   •       •      –    2025-12-17 4 A $0.00 $0 D/D 121,700 268,700     -
   Gayer Charles K President and CCO   •       –      –    2025-12-17 4 A $0.00 $0 D/D 471,000 889,827     -
   Barnes Alane P Chief Legal Officer   •       •      –    2025-12-15 4 AS $7.65 $162,257 D/D (21,210) 315,726 -1%     
   Stonehouse Jon P Chief Executive Officer   •       •      –    2025-12-12 4 D $7.57 $207,176 D/D (27,368) 1,405,222     -
   Barnes Alane P Chief Legal Officer   •       •      –    2025-12-12 4 D $7.57 $64,648 D/D (8,540) 336,936     -
   Gayer Charles K President and CCO   •       •      –    2025-12-12 4 D $7.57 $61,930 D/D (8,181) 418,827     -
   Barnes Alane P Chief Legal Officer   •       •      –    2025-12-03 4 AS $7.65 $151,241 D/D (19,770) 345,476 -4%     
   Barnes Alane P Chief Legal Officer   •       •      –    2025-12-02 4 AS $7.21 $367,216 D/D (50,906) 365,246 5%     
   Barnes Alane P Chief Legal Officer   •       •      –    2025-12-01 4 AS $7.10 $646,511 D/D (91,004) 416,152 5%     
   Barnes Alane P Chief Legal Officer   •       •      –    2025-12-01 4 OE $3.22 $293,033 D/D 91,004 507,156     -
   Milano Vincent Director   •       •      –    2025-11-28 4 A $7.18 $5,622 D/D 783 91,219     -
   Frank Steven Director   •       •      –    2025-11-28 4 A $7.18 $11,244 D/D 1,566 17,618     -
   Mckee Amy E Director   •       •      –    2025-11-28 4 A $7.18 $5,622 D/D 783 41,790     -
   Sanders Machelle Director   •       •      –    2025-11-13 4 AS $7.14 $68,544 D/D (9,600) 30,642 9%     
   Milano Vincent Director   •       •      –    2025-08-29 4 A $8.31 $5,618 D/D 676 90,436     -
   Mckee Amy E Director   •       •      –    2025-08-29 4 A $8.31 $5,618 D/D 676 41,007     -
   Frank Steven Director   •       •      –    2025-08-29 4 A $8.31 $11,243 D/D 1,353 16,052     -

  476 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed